Chemical denervation for the treatment of hypertonia and related motor disorders: Phenol and botulinum toxin

被引:5
|
作者
Glenn, MB
Elovic, E
机构
[1] BOSTON MED CTR,DIV REHABIL MED,BOSTON,MA
[2] JFK JOHNSON REHABIL INST,CTR HEAD INJURIES,EDISON,NJ
[3] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHYS MED & REHABIL,EDISON,NJ
关键词
botulinum toxin; chemical denervation; chemical neurolysis; neuromuscular blockade; phenol; PAINFUL HEMIPLEGIC SHOULDER; UPPER EXTREMITY SPASTICITY; SPASMODIC TORTICOLLIS; CERVICAL DYSTONIA; NERVE BLOCK; A TOXIN; MUSCLE; INJECTIONS; COMPLICATIONS; RIGIDITY;
D O I
10.1097/00001199-199712000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chemical neurolysis with phenol and neuromuscular blockade with botulinum toxin (Btx) are two commonly used approaches to chemical denervation (CD) for the treatment of hypertonia and related motor disorders. Physiologic and therapeutic effects, technique, safety and toxicology, and side effects and complications are discussed for each. The patient can be approached by first considering whether CD is indicated in the context of other available options. A kinesiologic and functional evaluation is used to determine the target goals according to impairment and disability. If CD is indicated, the clinician must decide whether neuromuscular blockade with Btx or chemical neurolysis with phenol is a better choice by considering the advantages and disadvantages of each for a given situation. If chemical neurolysis with phenol is indicated, then one must consider whether motor branch or mixed sensorimotor block is more worthwhile.
引用
收藏
页码:40 / 62
页数:23
相关论文
共 50 条
  • [31] The emerging role of botulinum toxin in the treatment of temporomandibular disorders
    Song, P. C.
    Schwartz, J.
    Blitzer, A.
    ORAL DISEASES, 2007, 13 (03) : 253 - 260
  • [32] Botulinum toxin A: Analgesic treatment for temporomandibular joint disorders
    Denglehem, C.
    Maes, J. -M.
    Raoul, G.
    Ferri, J.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2012, 113 (01) : 27 - 31
  • [33] The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders
    María T. Gómez-Caravaca
    María T. Cáceres-Redondo
    Ismael Huertas-Fernández
    Laura Vargas-González
    Fátima Carrillo
    Manuel Carballo
    Pablo Mir
    Neurological Sciences, 2015, 36 : 275 - 279
  • [34] The use of botulinum toxin treatment in children with movement disorders
    Autti-Ramo, I
    Larsen, TA
    Peltonen, J
    Kallio, P
    Nopola-Hemmi, J
    Siltanen, K
    Paltto, M
    Jantti, S
    Tornikoski, P
    Jaakkola, R
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 : S23 - S25
  • [35] The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders
    Gomez-Caravaca, Maria T.
    Caceres-Redondo, Maria T.
    Huertas-Fernandez, Ismael
    Vargas-Gonzalez, Laura
    Carrillo, Fatima
    Carballo, Manuel
    Mir, Pablo
    NEUROLOGICAL SCIENCES, 2015, 36 (02) : 275 - 279
  • [36] BOTULINUM TOXIN AND ITS USES IN THE TREATMENT OF OCULAR DISORDERS
    ALPAR, AJ
    AMERICAN JOURNAL OF OPTOMETRY AND PHYSIOLOGICAL OPTICS, 1987, 64 (02): : 79 - 82
  • [37] The use of botulinum toxin for the treatment of gastrointestinal motility disorders
    Friedenberg, F
    Gollamudi, S
    Parkman, HP
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (02) : 165 - 175
  • [38] BOTULINUM TOXIN IN THE TREATMENT OF FOCAL MOVEMENT-DISORDERS
    BURGUNDER, JM
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 122 (36) : 1311 - 1316
  • [39] Botulinum toxin in the motor disorders of the upper G-I tract
    Annese, V
    Andriulli, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R10 - R10
  • [40] Clinical comparison of botulinum toxin in motor and autonomic disorders: Similarities and differences
    Naumann, M.
    TOXICON, 2015, 107 : 68 - 71